Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 11, 2021

Gritstone Oncology Announces Private Placement Financings Totaling $125 Million

December 28, 2020

Gritstone Oncology Announces $110 Million Private Placement

December 23, 2020

Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights

November 5, 2020

Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE

November 2, 2020

Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference

September 15, 2020

Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September

September 8, 2020

Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights

August 5, 2020

Gritstone Oncology to Present at Two Upcoming Investor Conferences in August

August 3, 2020

Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13

June 24, 2020

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

© 2022 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Contact

socials

Top